Effects of a national quality improvement program on ICUs in China: a controlled pre-post cohort study in 586 hospitals

Critical Care : the Official Journal of the Critical Care Forum
Huaiwu HeChina-NCCQC group

Abstract

Patient safety and critical care quality remain a challenging issue in the ICU. However, the effects of the national quality improvement (QI) program remain unknown in China. A national ICU QI program was implemented in a controlled cohort of 586 hospitals from 2016 to 2018. The effects of the QI program on critical care quality were comprehensively investigated. A total of 81,461,554 patients were enrolled in 586 hospitals, and 1,587,724 patients were admitted to the ICU over 3 years. In 2018, there was a significantly higher number of ICU beds (2016 vs. 2018: 10668 vs. 13,661, P = 0.0132) but a lower doctor-to-bed ratio (2016 vs. 2018: 0.64 (0.50, 0.83) vs. 0.60 (0.45, 0.75), P = 0.0016) and nurse-to-bed ratio (2016 vs. 2018: 2.00 (1.64, 2.50) vs. 2.00 (1.50, 2.40), P = 0.031) than in 2016. Continuous and significant improvements in the ventilator-associated pneumonia (VAP) incidence rate, microbiology detection rate before antibiotic use and deep vein thrombosis (DVT) prophylaxis rate were associated with the implementation of the QI program (VAP incidence rate (per 1000 ventilator-days), 2016 vs. 2017 vs. 2018: 11.06 (4.23, 22.70) vs. 10.20 (4.25, 23.94) vs. 8.05 (3.13, 17.37), P = 0.0002; microbiology detection rate before...Continue Reading

References

Jul 29, 2006·Human Resources for Health·Stefane M KabeneRaymond Leduc
Jul 29, 2006·Intensive Care Medicine·Andreas ValentinUNKNOWN Sentinel Events Evaluation Study Investigators
Jan 21, 2011·JAMA : the Journal of the American Medical Association·Damon C ScalesMerrick Zwarenstein
Mar 23, 2011·The New England Journal of Medicine·Deborah CookNicholas E Vlahakis
Oct 4, 2011·Critical Care Medicine·Maite Garrouste-OrgeasUNKNOWN Outcomerea Study Group
Oct 23, 2013·Critical Care Medicine·William CheckleyUNKNOWN United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study Investigators
Jan 10, 2014·American Journal of Respiratory and Critical Care Medicine·Allan J Walkey, Renda Soylemez Wiener
Mar 19, 2014·The New England Journal of Medicine·Donald M YealyDerek C Angus
Oct 2, 2014·The New England Journal of Medicine·Sandra L PeakePatricia Williams
Dec 6, 2014·Critical Care Medicine·Yasser SakrUNKNOWN Extended Prevalence of Infection in Intensive Care Study Investigators
Jan 21, 2015·Intensive Care Medicine·Georg Heinrich KlugeEmiel S Boon
Mar 18, 2015·The New England Journal of Medicine·Paul R MounceyUNKNOWN ProMISe Trial Investigators
Feb 24, 2016·JAMA : the Journal of the American Medical Association·Deena Kelly Costa, Jeremy M Kahn
Apr 27, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Group for the CHECKLIST-ICU Investigators and the Brazilian Research in Intensive Care Network (BRICNet)Otavio Berwanger
May 29, 2016·Respiratory Care·Michael Klompas, Lorenzo Berra
Jun 28, 2016·Critical Care Medicine·Yaseen M ArabiUNKNOWN Asian Critical Care Clinical Trials Group
Apr 25, 2017·Critical Care Medicine·Elisa EstenssoroUNKNOWN Latin-American Intensive Care Network (LIVEN)
Jun 5, 2017·Seminars in Respiratory and Critical Care Medicine·Girish B Nair, Michael S Niederman
Nov 21, 2017·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Payal K PatelJennifer Meddings
May 31, 2018·Intensive Care Medicine·Li WengUNKNOWN China Critical Care Clinical Trials Group (CCCCTG)
Jul 10, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ana BonellBehzad Nadjm

❮ Previous
Next ❯

Citations

Mar 21, 2021·European Journal of Medical Research·Lu WangUNKNOWN China National Critical Care Quality Control Center Group
Oct 9, 2021·Journal of Intensive Care·Jason PhuaUNKNOWN Asian Critical Care Clinical Trials Group

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.